|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dockets Entered On November
3, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket
#
|
| Title
|
|
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry:
Opportunity for Hearing
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency
Contraceptives from Rx to OTC
|
|
|
|
|
| 2003D-0383
|
| Draft Guidance for
Industry and FDA Staff; Use of Symbols on Labels and in Labeling of
In Vitro Diagnostic Devices Intended for Professional Use; Availability
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans
Fatty Acids in Nutrition Labeling; Consumer research to consider possible
footnote statements
|
|
|
|
|
| 2003P-0477
|
| Expedite the revocation
of determination of the application of the AIP
|
|
|
|
|
| 2004D-0453
|
| Compliance Policy
Guide Sec. 560.400 - "Imported Milk and Cream Federal Import
Milk Act (CPG 7119.05)"
|
|
|
|
|
| 2004N-0179
|
| Agency Information
Collection Activities: Proposed Collection; Comment Request; New Animal
Drug Application, FDA Form 356 V, 21 CFR Part 514
|
|
|
|
|
| 2004N-0245
|
| Current Good Manufacturing
Practice Regulations for Medicated Feeds, 21 CFR Part 225
|
|
|
|
|
| 2004N-0264
|
| Federal Measures to
Mitigate BSE Risks: Considerations for Further Action
|
|
|
|
|
| 2004N-0269
|
| Radioactive Drug Research
Committees; Agency Information Collection Activities
|
|
|
|
|
| 2004N-0408
|
| Regulatory Site Visit
Training Program
|
|
|
|
|
| 2004N-0436
|
| Agency Information
Collection Activities: Proposed Collection; Comment Request;
|
|
|
|
|
| 2004N-0454
|
| Dietary Supplements;
Premarket Notification for New Dietary Ingredient Notifications; Public
Meeting
|
|
|
|
|
| 2004N-0469
|
| Agency Information
Collection Activities: Proposed Collection; Comment Request; Adverse
Experience Reporting for Licensed Biological Products; and General
Records
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for
Poultry: Opportunity for Hearing
|
|
|
| EXB 670
|
| Bayer Corporation
|
| Vol #:
|
| 459
|
|
|
|
|
| EXB 671
|
| Bayer Corporation
|
| Vol #:
|
| 459
|
|
|
|
|
| EXB 672
|
| Bayer Corporation
|
| Vol #:
|
| 459
|
|
|
|
|
| EXB 673
|
| Bayer Corporation
|
| Vol #:
|
| 459
|
|
|
|
|
| EXB 674
|
| Bayer Corporation
|
| Vol #:
|
| 459
|
|
|
|
|
| 2001P-0075
|
| Switch Status of
Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| EMC 10982
|
| O. Morderer
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 10983
|
| L. Finstad
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 10984
|
| L. Finstad
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 10985
|
| A. Dew
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 10986
|
| L. Lucano
|
| Vol #:
|
| 296
|
|
|
|
|
| 2003D-0383
|
| Draft Guidance
for Industry and FDA Staff; Use of Symbols on Labels and in Labeling
of In Vitro Diagnostic Devices Intended for Professional Use; Availability
|
|
|
|
|
| NAL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| SS
1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0076
|
| Food Labeling:
Trans Fatty Acids in Nutrition Labeling; Consumer research to consider
possible footnote statements
|
|
|
|
|
| EMC 447
|
| B. Graham
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 448
|
| K. Hartzell
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 449
|
| K. Hartzell
|
| Vol #:
|
| 9
|
|
| | | | | | | | |
|
| |
|
| 2003P-0477
|
| Expedite the revocation of determination of the application of the AIP
|
|
|
|
|
| WDL 1
|
| Number not used
|
| Vol #:
|
| 2
|
|
|
|
|
| 2004D-0453
|
| Compliance Policy Guide Sec. 560.400 - "Imported Milk and Cream Federal Import Milk Act (CPG 7119.05)"
|
|
|
|
|
| GDL
1
|
| GUIDANCE
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0179
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; New Animal Drug Application, FDA Form 356 V, 21 CFR Part 514
|
|
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0245
|
| Current Good Manufacturing Practice Regulations for Medicated Feeds, 21 CFR Part 225
|
|
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0264
|
| Federal Measures to Mitigate BSE Risks: Considerations for Further Action
|
|
|
|
|
| C 193
|
| F. Bayod
|
| Vol #:
|
| 23
|
|
|
|
|
| 2004N-0269
|
| Radioactive Drug Research Committees; Agency Information Collection Activities
|
|
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0408
|
| Regulatory Site Visit Training Program
|
|
|
|
|
| LET
3
|
| Solvay Pharmaceuticals
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0436
|
| Agency Information Collection Activities: Proposed Collection; Comment Request;
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
| |
|
| 2004N-0454
|
| Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
|
|
|
|
|
| EXT
1
|
| AHPA, CHPA,CRN,NNFA and UNPA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0469
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Adverse Experience Reporting for Licensed Biological Products; and General Records
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
